A Dose-ranging Study to Evaluate the Safety and Efficacy of LUSEDRA (Fospropofol Disodium) as an Intravenous Sedative for Diagnostic or Therapeutic Colonoscopy in Adult Special Populations

NCT01127438 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

153

Enrollment

INDUSTRY

Sponsor class

Conditions

Sedation

Interventions

DRUG: fospropofol disodium Subgroup 1 Lower Dose
DRUG: fospropofol disodium Subgroup 1 Approved Dose
DRUG: fospropofol disodium Subgroup 2 Lower Dose
DRUG: fospropofol disodium Subgroup 2 Approved Dose
DRUG: fospropofol disodium Subgroup 3 Lower Dose
DRUG: fospropofol disodium Subgroup 3 Approved Dose

Sponsor

Eisai Inc.